Dolutegravir 50 mg and Lamivudine 300 mg Tablets
Dolutegravir 50 mg and Lamivudine 300 mg are two distinct antiretroviral medicines used in the management of HIV-1 infection. While Dolutegravir acts as an integrase inhibitor, Lamivudine is a nucleoside reverse transcriptase inhibitor. Both medicines are essential components in HIV therapy and are manufactured separately, maintaining their purity and efficacy.
Kureasia Pharma provides high-quality third party and contract manufacturing services for these tablets under strict WHO-GMP certified facilities.
Composition & Strength of Individual Tablets
| Medicine | Strength | Formulation |
|---|---|---|
| Dolutegravir | 50 mg | Film-coated tablet |
| Lamivudine | 300 mg | Film-coated tablet |
Both tablets are designed for once-daily administration, providing patients with an effective and convenient treatment regimen.
Therapeutic Applications & Benefits
Dolutegravir 50 mg
Used as an integrase inhibitor in HIV-1 treatment
Reduces viral replication and improves immune response
Well-tolerated with minimal side effects
Lamivudine 300 mg
Acts as a nucleoside reverse transcriptase inhibitor (NRTI)
Prevents viral replication in host cells
Can be used alone or with other antiretroviral agents
Benefits of Third Party Manufacturing
High-quality, WHO-GMP certified production
Ensures consistent potency and safety
Flexible packaging options for pharma companies
Manufacturing Excellence at Kureasia Pharma
Kureasia Pharma specializes in separate manufacturing of Dolutegravir and Lamivudine Tablets with high precision:
WHO-GMP certified production facilities
Advanced quality control processes and testing
Stability and dissolution analysis for each batch
Customizable packaging: blisters, bottles, or bulk supply
Compliance with national and international regulatory standards
Third Party & Contract Manufacturing Services
We offer complete contract manufacturing solutions for Dolutegravir 50 mg and Lamivudine 300 mg Tablets:
Product formulation and R&D support
Regulatory documentation and approvals
Private labeling and custom packaging
Bulk manufacturing and timely dispatch
Flexible Minimum Order Quantities (MOQs)
This allows pharmaceutical companies to expand their product portfolio efficiently without investing in their own manufacturing infrastructure.
Global Reach & Partner Advantages
Kureasia Pharma exports both Dolutegravir 50 mg and Lamivudine 300 mg Tablets worldwide:
Export countries: Nigeria, Kenya, Ghana, Vietnam, and more
Fully compliant with international standards and WHO-GMP
Reliable logistics, documentation, and after-sales support
Why Partner with Kureasia Pharma
Separate manufacturing for Dolutegravir and Lamivudine ensures purity
WHO-GMP & ISO certified facilities (Delhi & Haridwar)
Decade-long expertise in antiretroviral manufacturing
Affordable, scalable, and reliable production
Storage & Handling
Store below 30°C in a cool, dry place
Protect from moisture and direct sunlight
Keep out of reach of children
Contact Us
Information
Contact Numbers:
+91 95577 45784 | +91 93110 19560 | 011-40234824
Email: sales@kureasiapharma.com
Corporate Office: B-255, Third Floor, Munshi Ram Gupta Marg, Naraina Industrial Area Phase 1, New Delhi 110028
Manufacturing Unit: Industrial Area, Plot Number-1, Khasra No. 882, 883K, Village-Salempur, Mehdood-II, Haridwar 249402, INDIA
Let’s Discuss Your Requirements
Your Trusted Pharma Partner—From Formulation to Fulfillment
Join hands with Kureasia Pharma’s advanced production line for tablets, syrups, ointments, and more.
Copyright © 2025 Kureasia Pharma | Developed by OTD